TECTONIC THERAPEUTIC, INC. Other Income and Expense
TECTONIC THERAPEUTIC, INC. (TECX) reported Other Income and Expense of $2.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. nonoperating income (expense) for the quarter ending 2026-06-30 was $2.01M, a 39.53% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. nonoperating income (expense) for the quarter ending 2026-03-31 was $2.06M, a 13.88% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. nonoperating income (expense) for the quarter ending 2025-12-31 was $2.54M, a 57.23% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. nonoperating income (expense) for the quarter ending 2025-09-30 was $2.85M, a 48.70% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. nonoperating income (expense) for fiscal 2025 was $11.12M, a 33581.82% increase from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. nonoperating income (expense) for fiscal 2024 was $33.00K, a 98.19% decline from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. nonoperating income (expense) for fiscal 2023 was $1.82M.
- TECTONIC THERAPEUTIC, INC. nonoperating income (expense) for fiscal 2022 was -$456.00K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 3 month as first filed | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 6 month as first filed | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 9 month as first filed | Nonoperating Income (Expense) 12 month | Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.01M 10-Q · filed 2026-08-06 | $4.07M 10-Q · filed 2026-08-06 | $6.61M derived: sum of 3 quarters · filed 2026-08-06 | $9.47M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $2.06M 10-Q · filed 2026-05-07 | $4.60M derived: sum of 2 quarters · filed 2026-05-07 | $7.46M derived: sum of 3 quarters · filed 2026-05-07 | $10.78M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.40M derived: sum of 2 quarters · filed 2026-02-26 | $8.72M derived: sum of 3 quarters · filed 2026-08-06 | $11.12M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $2.85M 10-Q · filed 2025-11-06 | $6.18M derived: sum of 2 quarters · filed 2026-08-06 | $8.57M 10-Q · filed 2025-11-06 | $10.19M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $3.32M 10-Q · filed 2026-08-06 | $5.72M 10-Q · filed 2026-08-06 | $7.33M derived: sum of 3 quarters · filed 2026-08-06 | $9.25M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $2.39M 10-Q · filed 2026-05-07 | $4.01M derived: sum of 2 quarters · filed 2026-05-07 | $5.93M derived: sum of 3 quarters · filed 2026-05-07 | $4.68M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.54M derived: sum of 2 quarters · filed 2026-02-26 | $2.29M derived: sum of 3 quarters · filed 2026-02-26 | $33.00K 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $1.92M 10-Q · filed 2025-11-06 | $670.00K derived: sum of 2 quarters · filed 2025-11-06 | -$1.58M 10-Q · filed 2025-11-06 | -$78.00K derived: sum of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | -$1.25M 10-Q · filed 2025-08-07 | -$3.50M 10-Q · filed 2025-08-07 | -$2.00M derived: sum of 3 quarters · filed 2025-08-07 | -$1.94M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$2.25M 10-Q · filed 2025-05-08 | $1.13M 10-Q · filed 2024-05-09 | -$748.00K derived: sum of 2 quarters · filed 2025-05-08 | -$688.00K derived: sum of 3 quarters · filed 2025-05-08 | -$512.00K derived: sum of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $1.56M derived: sum of 2 quarters · filed 2025-03-20 | $1.74M derived: sum of 3 quarters · filed 2025-03-20 | $1.82M 10-K · filed 2025-03-20 | $2.34M 10-K · filed 2024-03-14 | |||
| 2023-09-30 | $60.00K 10-Q · filed 2024-11-12 | $1.36M 10-Q · filed 2023-11-09 | $236.00K derived: sum of 2 quarters · filed 2024-11-12 | $320.00K 10-Q · filed 2024-11-12 | $1.09M 10-Q · filed 2023-11-09 | $722.00K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $176.00K 10-Q · filed 2024-08-14 | -$531.00K 10-Q · filed 2023-08-10 | $262.00K 10-Q · filed 2024-08-14 | -$268.00K 10-Q · filed 2023-08-10 | $662.00K derived: sum of 3 quarters · filed 2024-08-14 | $678.00K derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $263.00K 10-Q · filed 2024-05-09 | $486.00K derived: sum of 2 quarters · filed 2024-05-09 | $502.00K derived: sum of 3 quarters · filed 2024-05-09 | $222.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $239.00K derived: sum of 2 quarters · filed 2024-03-14 | -$41.00K derived: sum of 3 quarters · filed 2024-03-14 | -$456.00K 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | $16.00K 10-Q · filed 2023-11-09 | -$264.00K derived: sum of 2 quarters · filed 2023-11-09 | -$679.00K 10-Q · filed 2023-11-09 | -$944.00K derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$280.00K 10-Q · filed 2023-08-10 | -$695.00K 10-Q · filed 2023-08-10 | -$960.00K derived: sum of 3 quarters · filed 2023-08-10 | -$953.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$415.00K 10-Q · filed 2023-05-11 | -$680.00K derived: sum of 2 quarters · filed 2023-05-11 | -$673.00K derived: sum of 3 quarters · filed 2023-05-11 | -$685.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$258.00K derived: sum of 2 quarters · filed 2023-03-23 | -$270.00K derived: sum of 3 quarters · filed 2023-03-23 | -$285.00K 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $7.00K 10-Q · filed 2022-11-08 | -$5.00K derived: sum of 2 quarters · filed 2022-11-08 | -$20.00K 10-Q · filed 2022-11-08 | -$87.00K derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$12.00K 10-Q · filed 2022-08-09 | -$27.00K 10-Q · filed 2022-08-09 | -$94.00K derived: sum of 3 quarters · filed 2022-08-09 | -$156.00K derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$15.00K 10-Q · filed 2022-05-10 | -$82.00K derived: sum of 2 quarters · filed 2022-05-10 | -$144.00K derived: sum of 3 quarters · filed 2022-05-10 | -$115.00K derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$129.00K derived: sum of 2 quarters · filed 2022-03-17 | -$100.00K derived: sum of 3 quarters · filed 2022-03-17 | $516.00K 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | -$62.00K 10-Q · filed 2021-11-04 | -$33.00K derived: sum of 2 quarters · filed 2021-11-04 | $583.00K 10-Q · filed 2021-11-04 | $1.35M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $29.00K 10-Q · filed 2021-08-05 | $645.00K 10-Q · filed 2021-08-05 | $1.42M derived: sum of 3 quarters · filed 2021-08-05 | $2.33M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $616.00K 10-Q · filed 2021-05-13 | $1.39M derived: sum of 2 quarters · filed 2021-05-13 | $2.31M derived: sum of 3 quarters · filed 2021-05-13 | $2.86M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $771.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $1.69M derived: sum of 2 quarters · filed 2021-03-18 | $2.25M derived: sum of 3 quarters · filed 2021-03-18 | $2.84M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $919.00K 10-Q · filed 2020-11-05 | $1.48M derived: sum of 2 quarters · filed 2020-11-05 | $2.07M 10-Q · filed 2020-11-05 | $2.73M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $557.00K 10-Q · filed 2020-08-06 | $1.15M 10-Q · filed 2020-08-06 | $1.81M derived: sum of 3 quarters · filed 2020-08-06 | $2.45M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $597.00K 10-Q · filed 2020-05-07 | $1.25M derived: sum of 2 quarters · filed 2020-05-07 | $1.89M derived: sum of 3 quarters · filed 2020-05-07 | $933.00K derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $655.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.30M derived: sum of 2 quarters · filed 2020-03-16 | $336.00K derived: sum of 3 quarters · filed 2020-03-16 | -$118.00K 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $641.00K 10-Q · filed 2019-11-07 | -$319.00K derived: sum of 2 quarters · filed 2019-08-08 | -$773.00K 10-Q · filed 2019-11-07 | -$939.00K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-06-30 | -$960.00K 10-Q · filed 2019-08-08 | -$1.41M 10-Q · filed 2019-08-08 | -$1.58M derived: sum of 3 quarters · filed 2019-08-08 | -$1.65M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$454.00K 10-Q · filed 2019-05-13 | -$620.00K derived: sum of 2 quarters · filed 2019-05-13 | -$691.00K derived: sum of 3 quarters · filed 2019-05-13 | -$683.00K derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | -$166.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | -$237.00K derived: sum of 2 quarters · filed 2019-03-25 | -$229.00K derived: sum of 3 quarters · filed 2019-03-25 | -$262.00K 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | -$71.00K 10-Q · filed 2018-11-13 | -$63.00K derived: sum of 2 quarters · filed 2018-11-13 | -$96.00K 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $8.00K 10-Q · filed 2018-08-09 | -$25.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |